BioSpace News Archive

Pharm Country

Todos Medical Provides Corporate Update - October 11, 2022

Todos Medical, Ltd., a comprehensive medical diagnostics and related solutions company, provided a corporate update for shareholders.

October 11, 2022
·
10 min read
Genetown

Zealand Pharma major shareholder announcement: Polar Capital

Zealand Pharma A/S announces the receipt on 11 October 2022 of notification pursuant to Section 38 of the Danish Capital Markets Act from the following major shareholders:

October 11, 2022
·
1 min read
Biotech Beach

CureDuchenne Launches Occupational Therapist Certification Program to Improve Care for Individuals with Duchenne Muscular Dystrophy

CureDuchenne, a global leader in research, patient care and innovation for improving and extending the lives of those with Duchenne muscular dystrophy, launched the CureDuchenne Occupational Therapist Certification Program.

October 11, 2022
·
4 min read
Lone Star Bio

Ascend continues broad expansion into new markets, launches HiDura™ MED portfolio

Ascend Performance Materials announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura™ brand.

October 11, 2022
·
2 min read
Biotech Beach

Family Heart Foundation Study Shows Some Children With Homozygous Familial Hypercholesterolemia Miss out on Decades of Life-Saving Treatment

The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of patients in its CASCADE FH® Registry showing that children with homozygous familial hypercholesterolemia are diagnosed earlier and have much higher untreated low-density lipoprotein cholesterol than adults with HoFH.

October 11, 2022
·
4 min read
Drug Development

GentiBio Announces Preclinical Data Showing Antigen Specific Engineered Tregs Suppressing Pancreatic Inflammation and Potential Utility for Treatment and Prevention of Clinical Type 1 Diabetes (T1D)

GentiBio, Inc., a biotherapeutics company developing engineered T regulatory (Treg) cells (EngTregs) therapies for autoimmune, auto-inflammatory, alloimmune and allergic diseases, today announced the release of preclinical data demonstrating a novel approach for using engineered Tregs to potentially treat and prevent type 1 diabetes (T1D).

October 11, 2022
·
5 min read
EnteroBiotix receives MHRA MIA (IMP) licensure of state-of-the-art GMP manufacturing facility for producing microbiome therapeutics

EnteroBiotix Limited, the premier full-spectrum microbiome therapeutics company, today announced that it has been granted a Manufacturer’s licence for Investigational Medicinal Products (IMP) by the Medicines and Healthcare Products Regulatory Agency (MHRA) to manufacture microbiome product candidates for clinical trials

October 11, 2022
·
2 min read
Synaptive Medical Partners with Panaxium to Bring Real-Time Intelligent High-Resolution Cortical Mapping to Neurosurgical OR

Synaptive Medical Inc. announced a joint-development partnership with bioelectronic medicine company Panaxium SAS to incorporate Panaxium’s ultra-flexible iontronic electrocorticography platform into Synaptive’s Modus V robotic exoscope technology.

October 11, 2022
·
4 min read
BioCapital

Parent Project Muscular Dystrophy Announces Pediatric Certified Duchenne Care Center at Stony Brook Children’s Hospital

Parent Project Muscular Dystrophy announced the expansion of their renowned Certified Duchenne Care Center Program with the certification of Stony Brook Children’s Hospital, in Stony Brook, New York.

October 11, 2022
·
5 min read
Major Grant Awarded to Study PCLX-001 in Acute Myeloid Leukemia Patients

Pacylex today announced that the US Department of Defense (DOD) awarded The University of Texas MD Anderson Cancer Center $1.4 million to treat Acute Myeloid Leukemia (AML) patients with PCLX-001, a first-in-class N-myristoylation inhibitor in clinical development

October 11, 2022
·
2 min read